CTRI/2024/01/061498招募中Unknown
A Clinically-Oriented Antimicrobial Resistance Surveillance Network for Healthcare-associated infections - ACORN-HAI
试验速览
- 阶段
- Unknown
- 状态
- 招募中
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Healthcare-associated bloodstream infection
- •1) Prescription/commencement of an intravenous antibiotic AND
- •2) Positive growth of bacterial or Candida spp pathogen(s) identified from blood specimen(s) taken on or after day 3 of admission (Day 1 refers to the day of admission), or within 3 months of significant healthcare exposure; AND
- •3) Bacterial pathogen(s) in the blood specimen(s) satisfies either of the following:
- •i) one or more non-common commensal bacterial pathogen(s) identified from one or more blood specimens obtained by a culture; OR
- •ii) the same common commensal bacterial pathogen identified from two or more blood specimens collected on separate occasions
- •Ventilator-associated pneumonia
- •1) Clinical suspicion of VAP; AND
- •2) Prescription/commencement of an intravenous antibiotic; AND
- •3) Positive growth of bacterial pathogen(s) identified from respiratory specimen(s) taken on or after day 3 of ventilation.
排除标准
- •Healthcare-associated bloodstream infection
- •Patient who has positive growth of organisms belonging to the following genera which are typically causes of community-associated infections and are rarely or are not known to be causes of healthcare-associated infections, or associated with severe immune suppression:
- •a)Burkholderia pseudomallei,
- •b)Brucella spp, including but not limited to, B. melitensis, B. abortus, B. suis, B. canis,
- •c)Campylobacter, Salmonella, Shigella, Listeria, Vibrio and Yersinia.
- •Ventilator-associated pneumonia
- •Patient who has positive growth of organisms belonging to the following genera which are typically causes of community-associated infections and/or are rarely or are not known to be causes of healthcare-associated infections:
- •a)Streptococcus pneumoniae, Streptococcus suis, Haemophilus influenzae,
- •b)Burkholderia pseudomallei,
- •c)Coagulase-negative staphylococci,
- •d)Talaromyces marneffei,
- •e)Mycobacterium Tuberculosis,
- •f)Rapidly growing Mycobacteria, including but not limited to, M. mucogenicum, M. fortuitum, M. abscessus, M. chelonae, M. neoaurum
研究者
相似试验
进行中（未招募）
1 期
Clinical relevance of the antimicrobial resistance testing in the treatment of chronic wounds with antisepticsDecubitus, acute or chronic wounds (open wounds existing = 14 days)EUCTR2018-003321-29-DERWTH Aachen University represented by the Rector himself, represented by the Dean of the Medical Faculty
尚未招募
不适用
To study Antimicrobial resistance of intestinal micro flora in people working in medical setting and non-medical setting.CTRI/2020/03/024275Kasturba Medical College Manipal
尚未招募
不适用
Clinical predictive of antimicrobial resistance bacteremia at the Emergency Departmentantimicrobial resistance bacteremia antibiotic stewardshipTCTR20200909003Research Affairs, Faculty of Medicine, Khon Kaen University200
已完成
不适用
Study of antimicrobial resistance in patients receiving outpatient parenteral antimicrobial therapyAntimicrobial resistance (AMR)Infections and InfestationsISRCTN15309500Cambridge University Hospitals NHS Foundation Trust40
已完成
不适用
emergence of antibiotic resistanceapical periodontitisendodonticsTCTR20220118002scientific projects unit45